$AVD
AMERICAN VANGUARD CORP

2015 Q2 Form 10-Q Financial Statement

#000119312515272414 Filed on July 31, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $66.52M $68.31M
YoY Change -2.62% -21.26%
Cost Of Revenue $41.40M $42.25M
YoY Change -2.01% -5.46%
Gross Profit $25.12M $26.06M
YoY Change -3.6% -38.05%
Gross Profit Margin 37.76% 38.15%
Selling, General & Admin $18.60M $20.30M
YoY Change -8.37% -15.77%
% of Gross Profit 74.04% 77.9%
Research & Development $5.300M $5.000M
YoY Change 6.0% -1.96%
% of Gross Profit 21.1% 19.19%
Depreciation & Amortization $3.910M $4.270M
YoY Change -8.43% 13.56%
% of Gross Profit 15.56% 16.39%
Operating Expenses $23.92M $25.34M
YoY Change -5.58% -13.14%
Operating Profit $1.199M $723.0K
YoY Change 65.84% -94.39%
Interest Expense $662.0K $857.0K
YoY Change -22.75% 22.25%
% of Operating Profit 55.21% 118.53%
Other Income/Expense, Net
YoY Change
Pretax Income $537.0K -$121.0K
YoY Change -543.8% -100.99%
Income Tax -$393.0K -$160.0K
% Of Pretax Income -73.18%
Net Earnings $781.0K $145.0K
YoY Change 438.62% -98.27%
Net Earnings / Revenue 1.17% 0.21%
Basic Earnings Per Share $0.03 $0.01
Diluted Earnings Per Share $0.03 $0.01
COMMON SHARES
Basic Shares Outstanding 28.68M shares 28.41M shares
Diluted Shares Outstanding 29.20M shares 28.80M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.100M $4.200M
YoY Change 21.43% -87.04%
Cash & Equivalents $5.089M $4.189M
Short-Term Investments
Other Short-Term Assets $21.80M $20.50M
YoY Change 6.34% 12.02%
Inventory $165.2M $175.2M
Prepaid Expenses
Receivables $74.70M $73.24M
Other Receivables $4.750M $13.00M
Total Short-Term Assets $278.5M $286.2M
YoY Change -2.7% 15.97%
LONG-TERM ASSETS
Property, Plant & Equipment $48.98M $51.62M
YoY Change -5.13% 3.6%
Goodwill
YoY Change
Intangibles $103.9M
YoY Change -5.79%
Long-Term Investments $2.981M $2.561M
YoY Change 16.4%
Other Assets $32.42M $37.75M
YoY Change -14.13% 24.29%
Total Long-Term Assets $214.5M $193.2M
YoY Change 11.01% 1.46%
TOTAL ASSETS
Total Short-Term Assets $278.5M $286.2M
Total Long-Term Assets $214.5M $193.2M
Total Assets $493.0M $479.4M
YoY Change 2.83% 9.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.02M $23.90M
YoY Change -16.24% -0.22%
Accrued Expenses $69.60M $74.36M
YoY Change -6.4% -15.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.07M $70.00K
YoY Change 14288.57% 0.0%
Total Short-Term Liabilities $111.4M $107.3M
YoY Change 3.8% -12.87%
LONG-TERM LIABILITIES
Long-Term Debt $87.61M $86.09M
YoY Change 1.77% 110.43%
Other Long-Term Liabilities $2.994M $4.000M
YoY Change -25.15% -6.98%
Total Long-Term Liabilities $90.61M $86.09M
YoY Change 5.25% 110.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $111.4M $107.3M
Total Long-Term Liabilities $90.61M $86.09M
Total Liabilities $230.1M $220.4M
YoY Change 4.43% 17.53%
SHAREHOLDERS EQUITY
Retained Earnings $202.7M $201.9M
YoY Change 0.4% 2.95%
Common Stock $70.88M $3.153M
YoY Change 2147.89% 1.74%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.269M $8.269M
YoY Change 0.0% 72.13%
Treasury Stock Shares 2.451M shares 2.451M shares
Shareholders Equity $262.8M $259.6M
YoY Change
Total Liabilities & Shareholders Equity $493.0M $479.4M
YoY Change 2.83% 9.65%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $781.0K $145.0K
YoY Change 438.62% -98.27%
Depreciation, Depletion And Amortization $3.910M $4.270M
YoY Change -8.43% 13.56%
Cash From Operating Activities $23.98M $12.85M
YoY Change 86.61% -66.35%
INVESTING ACTIVITIES
Capital Expenditures -$1.960M -$2.130M
YoY Change -7.98% -46.21%
Acquisitions
YoY Change
Other Investing Activities -$36.56M $0.00
YoY Change
Cash From Investing Activities -$38.52M -$2.130M
YoY Change 1708.45% -46.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.89M -14.99M
YoY Change -185.99% 31.72%
NET CHANGE
Cash From Operating Activities 23.98M 12.85M
Cash From Investing Activities -38.52M -2.130M
Cash From Financing Activities 12.89M -14.99M
Net Change In Cash -1.650M -4.270M
YoY Change -61.36% -118.7%
FREE CASH FLOW
Cash From Operating Activities $23.98M $12.85M
Capital Expenditures -$1.960M -$2.130M
Free Cash Flow $25.94M $14.98M
YoY Change 73.16% -64.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2927 pure
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29201607 shares
CY2014Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
64057000
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8712000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4189000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
697854 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.71
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.21
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
260603000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660573 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.72
CY2015Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2118 pure
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2015Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.02
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.29
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31617282 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2015Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
271083000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
111353000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
87576000
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
87614000
CY2015Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
28159000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69603000
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
10072000
CY2015Q2 us-gaap Liabilities
Liabilities
230120000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
3162000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
67714000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
123000
CY2015Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
5052000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2994000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4509000
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2541000
CY2015Q2 us-gaap Minority Interest
MinorityInterest
69000
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
97686000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
202748000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
262814000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
493003000
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
262883000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20019000
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2098000
CY2015Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
140142000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48975000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
278484000
CY2015Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
25092000
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8731000
CY2015Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4750000
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5990000
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
133129000
CY2015Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6849000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5089000
CY2015Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
79448000
CY2015Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2015Q2 us-gaap Assets
Assets
493003000
CY2015Q2 us-gaap Equity Method Investments
EquityMethodInvestments
2981000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13133000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74698000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
136551000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32415000
CY2015Q2 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
4148000
CY2015Q2 us-gaap Inventory Net
InventoryNet
165234000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
100211000
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5964000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4885000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6680000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
724904 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.82
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.22
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31550477 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
269906000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
81245000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
83215000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
98605000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
28159000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52546000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
71000
CY2014Q4 us-gaap Liabilities
Liabilities
211318000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
3156000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
66232000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
166000
CY2014Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
5962000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3309000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
898000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1970000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
-634000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
98676000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
202488000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
261637000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
472321000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
261003000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20411000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1357000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
142853000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50026000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
287049000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22778000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8731000
CY2014Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2396000
CY2014Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
88423000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2014Q4 us-gaap Assets
Assets
472321000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13415000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
86027000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
133241000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35035000
CY2014Q4 us-gaap Inventory Net
InventoryNet
165631000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4591 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28404000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.270 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-29039000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28877000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
473000 shares
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
262000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2728000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1109000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2972000
us-gaap Operating Income Loss
OperatingIncomeLoss
4429000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1025000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35410000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
31000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
281000
us-gaap Sales Revenue Net
SalesRevenueNet
149408000
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
256000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-312000
us-gaap Payments Of Dividends
PaymentsOfDividends
2836000
us-gaap Profit Loss
ProfitLoss
1976000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
130554000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-396000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
3954000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5049000
us-gaap Net Income Loss
NetIncomeLoss
2304000
us-gaap Gross Profit
GrossProfit
54965000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-31000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
143000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1531000
us-gaap Interest Expense
InterestExpense
1488000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
90000
us-gaap Operating Expenses
OperatingExpenses
50536000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
175000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
30412000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
120000
us-gaap Cost Of Revenue
CostOfRevenue
94443000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7996000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
856000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1806000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-328000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3027000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2276000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2581000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1806000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
16264000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
34430000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16521000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
262000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
1196000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3954000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
18854000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
2116000
avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-140000
us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
dei Document Type
DocumentType
10-Q
dei Trading Symbol
TradingSymbol
AVD
dei Entity Central Index Key
EntityCentralIndexKey
0000005981
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2015-04-03
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28602000 shares
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2015-04-17
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-3.391 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
43824000
dei Amendment Flag
AmendmentFlag
false
us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2015-03-16
dei Entity Registrant Name
EntityRegistrantName
AMERICAN VANGUARD CORP
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29103000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
501000 shares
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
7000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
261000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
899000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
202000
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
125000
us-gaap Operating Income Loss
OperatingIncomeLoss
1505000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-8975000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-397000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
87000
us-gaap Sales Revenue Net
SalesRevenueNet
133088000
us-gaap Payments Of Dividends
PaymentsOfDividends
1141000
us-gaap Profit Loss
ProfitLoss
696000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
117313000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-191000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
36435000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
3480000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-143000
us-gaap Net Income Loss
NetIncomeLoss
832000
us-gaap Gross Profit
GrossProfit
49771000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-571000
us-gaap Interest Expense
InterestExpense
1390000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-387000
us-gaap Operating Expenses
OperatingExpenses
48266000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
154000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3193000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-878000
us-gaap Cost Of Revenue
CostOfRevenue
83317000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7864000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-685000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2485000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-136000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
2734000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
10000000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3611000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
591000
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
231000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2485000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
17851000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-11120000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-392000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-40000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-40040000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
15775000
avd Cash Dividend Paid
CashDividendPaid
572000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
887000
avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-191000
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10400 shares
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16650 shares
CY2015Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
280000
CY2015Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2015Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1245000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1427000
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-43000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-248000
CY2015Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
572000
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2385 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28408000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28795000 shares
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
387000 shares
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
382000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-121000
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
68313000
CY2014Q2 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-153000
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-29000
CY2014Q2 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
13000
CY2014Q2 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
145000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
723000
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
57379000
CY2014Q2 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
145000
CY2014Q2 us-gaap Gross Profit
GrossProfit
26060000
CY2014Q2 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-8000
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92000
CY2014Q2 us-gaap Interest Expense
InterestExpense
857000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
25337000
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
42253000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-160000
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-174000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1038000
CY2014Q2 avd Sales Of Non Crop Products
SalesOfNonCropProducts
10934000
CY2014Q2 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
39000
CY2014Q2 avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-68000
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2481 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28676000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
34800 shares
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29202000 shares
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
526000 shares
CY2015Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
-12000
CY2015Q2 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
6000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
458000
CY2015Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
937000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
537000
CY2015Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1058000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1199000
CY2015Q2 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
48000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
66523000
CY2015Q2 us-gaap Profit Loss
ProfitLoss
739000
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
57792000
CY2015Q2 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
781000
CY2015Q2 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
-125000
CY2015Q2 us-gaap Gross Profit
GrossProfit
25121000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-323000
CY2015Q2 us-gaap Interest Expense
InterestExpense
710000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
23922000
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
41402000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-393000
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-42000
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1058000
CY2015Q2 avd Sales Of Non Crop Products
SalesOfNonCropProducts
8731000
CY2015Q2 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
930000
CY2015Q2 avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-191000

Files In Submission

Name View Source Status
0001193125-15-272414-index-headers.html Edgar Link pending
0001193125-15-272414-index.html Edgar Link pending
0001193125-15-272414.txt Edgar Link pending
0001193125-15-272414-xbrl.zip Edgar Link pending
avd-20150630.xml Edgar Link completed
avd-20150630.xsd Edgar Link pending
avd-20150630_cal.xml Edgar Link unprocessable
avd-20150630_def.xml Edgar Link unprocessable
avd-20150630_lab.xml Edgar Link unprocessable
avd-20150630_pre.xml Edgar Link unprocessable
d937821d10q.htm Edgar Link pending
d937821dex311.htm Edgar Link pending
d937821dex312.htm Edgar Link pending
d937821dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending